Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats

European Journal of Pharmacology

Volumn 381, Issue 1, 1999, Pages 39-49

  Shimizu, Toshikatsu ^a   Hata, Satoshi ^a   Kuroda, Takayuki ^a   Mihara, Shin Ichi ^a   Fujimoto, Masafumi ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Endothelin; Endothelin receptor; Endothelin receptor antagonist; Proteinuria; Renal failure, chronic; Renal function; RT PCR (reverse transcription polymerase chain reaction)

Indexed keywords

CREATININE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CREATININE CLEARANCE; HYPERTENSION; KIDNEY FUNCTION; MALE; NEPHRECTOMY; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANIMALS; CAFFEIC ACIDS; CREATINE; DOWN-REGULATION; ENDOTHELINS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; OLEANOLIC ACID; PROTEIN PRECURSORS; PROTEINURIA; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; SULFONAMIDES;

EID: 0032857428     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00535-X     Document Type: Article

References (42)

1. Anderson S., Rennke H.G., Brenner B.M. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J. Clin. Invest. 77:1986;1993-2000.
2. Badr K.F., Murray J.J., Breyer M.D., Takahashi K., Inagami T., Harris R.C. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. J. Clin. Invest. 83:1989;336-342.
3. Benigni A., Zoja C., Corna D., Orisio S., Longaretti L., Bertani T., Remuzzi B. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int. 44:1993;440-444.
4. Brenner B.M., Troy J., Ballermaun B.J. Endothelium-dependent vascular response: mediators and mechanisms. J. Clin. Invest. 84:1989;1373-1378.
5. Catt K.J., Harwood J.P., Agunilera G., Dufau M.L. Hormonal regulation of peptide receptor and target cell responses. Nature (London). 280:1979;109-116.
6. Clozel M., Loffler B.M., Breu V., Hilfiger L., Maire J.P., Butscha B. Down regulation of endothelin receptors by autocrine production of endothelin-1. Am. J. Physiol. 265:1993;C188-C192.
7. 125I -endothelin-1 binding in rat kidney following in vivo labeling Am. J. Physiol. 267:1994;F845-F852.
8. Fukuda K., Yanagida T., Okuda S., Tamaki K., Ando T., Fujishima M. Role of endothelin as a mitogen in experimental glomerulonephritis in rats. Kidney Int. 49:1996;1320-1329.
9. B receptors in rats. Biochem. Biophys. Res. Commun. 199:1994;1461-1465.
10. B receptor antagonist ameliorates proteinuria and glomerular lesions in rat with proliferative nephritis. Kidney Int. 50:1996;962-972.
11. Hemsen, A., Modin, A., Weizberg, E., Rudehill, A., Nihlen, C., Ludberg, J.M., 1995. Bosentan increases plasma endothelin levels of ET-1, but not big ET-1 in the pig endotoxin shock model. 4th Int. Conf. Endothelin, April 24-26, London, C50, Abst.
12. Hirata Y., Yoshimi H., Takaichi S., Yanagisawa M., Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett. 239:1988;13-17.
13. Hocher B., Thone-Reineke C., Rohmeiss P., Schmager F., Slowinski T., Burst V., Siegmund F., Quertermous T., Bauer C., Neumayer H., Schleuning W., Theuring F. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J. Clin. Invest. 99:1997;1380-1389.
14. Jones C., Hiley C.R., Pelton J.T., Miller R.C. Autoradiographic localization of endothelin binding sites in kidney. Eur. J. Pharmacol. 163:1989;379-382.
15. Kawanishi, Y., Kanda, Y., Kohnoike, T., 1998. Novel pyrimidone compounds and drug compositions. Int. Pub. No. WO98/03488.
16. King A.J., Brenner B.M. Endothelium-derived vasoactive factors and the renal vasculature. Am. J. Physiol. 260:1991;R653-R622.
17. Kohan D. Endothelins in the kidney: physiology and pathophysiology. Am. J. Kidney Dis. 22:1993;493-510.
18. Kohono M., Horio T., Yokokawa K., Yasunari K., Kurihara N., Takeda T. Endothelin modulates the mitogenic effect of PDGF on glomerular mesangial cells. Am. J. Physiol. 226:1994;F894-F900.
19. Kohzuki M., Johnson C.I., Chai S.Y., Casley D.J., Mendelsohn F.A.O. Localization of endothelin receptors in the rat kidney. Eur. J. Pharmacol. 160:1989;193-194.
20. Kon V., Badr K.F. Biological actions and pathophysiologic signification of endothelin in the kidney. Kidney Int. 40:1991;1-12.
21. Koyama H., Nishizawa Y., Morii H., Tabata T., Inoue T., Yamaji T. Plasma endothelin levels in patients with uremia. Lancet. 1:1989;991-992.
22. Krapf R., Solioz M. Na/H antiporter mRNA expression in single nephron segments of rat kidney cortex. J. Clin. Invest. 88:1991;783-788.
23. Lin H.Y., Kaji E.H., Winkel G.K., Ives H.E., Lodish H.F. Cloning and functional expression of a vascular smooth muscle endothelin-1 receptor. Proc. Natl. Acad. Sci. U.S.A. 88:1991;3185-3189.
24. Marsen T.A., Schramek H., Dunn M. Renal actions of endothelin: linking cellular signaling pathways to kidney disease. Kidney Int. 45:1994;336-344.
25. Mattana J., Singhal R.P. L-Arginine supplementation antagonizes the effects of angiotensin II and endothelin-1 on mesangial cell proliferation. Cell. Physiol. Biochem. 5:1995;176-192.
26. Mihara S., Nakajima S., Matsumura S., Kohnoike T., Fujimoto M. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139. J. Pharmacol. Exp. Ther. 268:1993;1122-1128.
27. Nakamura T., Ebihara I., Fukui M., Osada S., Tomino Y., Masaki T., Goto K., Furuichi Y., Koide H. Renal expression of mRNAs for endothelin-1 and endothelin-3 and endothelin receptors in NZB/WF1 mice. Renal Physiol. Biochem. 16:1993;232-243.
28. Nakamura T., Ebihara I., Fukui M., Osada S., Tomino Y., Masaki T., Goto K., Furuichi Y., Koide H. Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephritis. J. Am. Soc. Nephrol. 5:1995;1585-1590.
29. Nitta K., Uchida K., Kimata N., Kawashima A., Yumura W., Nihei H. Endothelin-1 mediates erythropoietin-stimulated glomerular endothelial cell-dependent proliferation of mesangial cells. Eur. J. Pharmacol. 293:1995;491-494.
30. A receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur. J. Pharmacol. 225:1992;347-350.
31. Ohota K., Hirata Y., Shichri M., Kanno K., Emori T., Tomita K., Marumo F. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int. 39:1991;301-311.
32. Orisio S., Benigni A., Bruzzi I., Corna D., Perico N., Zoja C., Benatti L., Remussi G. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int. 43:1993;354-358.
33. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
34. Sakurai T., Yanagisawa M., Inoue A., Ryan U.S., Kimura S., Mitui Y., Goto K., Masaki T. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Commun. 175:1991;44-47.
35. Shimizu T., Nakamura M., Imai M. Renal action of a novel uricosuric diuretics, S-8666, clearance and tubular microinjection studies in rats. J. Pharmacol. Exp. Ther. 245:1988;644-650.
36. Shimizu T., Ikeda M., Kuroda T., Hata S., Fujimoto M. Potential contribution of endothelin to renal abnormalities in glycerol-induced acute renal failure in rats. J. Pharmacol. Exp. Ther. 286:1998;977-983.
37. Shomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
38. Simonson M.S. Endothelin: multifunctional renal peptides. Physiol. Rev. 73:1993;375-411.
39. Simonson M.S., Dunn M.J. The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. J. Lab. Clin. Med. 119:1992;622-639.
40. Suzuki N., Matsumoto H., Miyauchi T., Goto K., Masaki T., Tsuda M., Fujio M. Endothelin-3 concentrations in human plasma: the increased concentrations in patients undergoing haemodialysis. Biochem. Biophys. Res. Commun. 169:1990;809-815.
41. Takayanagi R., Kitazumi K., Tskasaki C., Ohnaka K., Aminoto S., Tasaki K., Ohashi M., Nakatani H. Presence of non selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett. 282:1991;103-106.
42. Warner T.D., deNucci G., Vane J.R. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur. J. Pharmacol. 159:1989;325-326.